This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.61 firm fixed-price delivery order is for the supply of the immunosuppressant drug Zortress (everolimus) 0.5 mg tablets, with a completion date of December 3, 2024.
The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This latest delivery order is not designated with a set-aside requirement, indicating open competition.
Generated 3/9/25, 12:46 AM